tiprankstipranks
Ildong Pharmaceutical Co., Ltd. (KR:249420)
:249420
South Korea Market
249420
Ildong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Ildong Pharmaceutical Co., Ltd. (249420) Financial Statements

― Followers

Ildong Pharmaceutical Co., Ltd. Financial Overview

Ildong Pharmaceutical Co., Ltd.'s market cap is currently ₩484.42B. The company's EPS TTM is $1418.03; its P/E ratio is 10.80; and it has a dividend yield of 1.31%. Ildong Pharmaceutical Co., Ltd. is scheduled to report earnings on July 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 566.93B₩ 614.94B₩ 600.76B₩ 637.71B₩ 560.13B
Gross Profit₩ 214.76B₩ 233.46B₩ 207.54B₩ 236.34B₩ 219.44B
Operating Income₩ 17.32B₩ 13.12B₩ -53.42B₩ -73.33B₩ -54.38B
EBITDA₩ 39.90B₩ 33.59B₩ -51.23B₩ -80.49B₩ -101.34B
Net Income₩ 27.66B₩ -4.58B₩ -78.93B₩ -142.17B₩ -99.71B
Balance Sheet
Cash & Short-Term Investments₩ 64.96B₩ 84.87B₩ 81.28B₩ 78.75B₩ 154.68B
Total Assets₩ 573.03B₩ 589.04B₩ 611.26B₩ 655.81B₩ 708.97B
Total Debt₩ 150.31B₩ 205.55B₩ 212.73B₩ 207.75B₩ 226.16B
Net Debt₩ 85.46B₩ 133.28B₩ 159.47B₩ 155.60B₩ 90.57B
Total Liabilities₩ 333.52B₩ 429.99B₩ 437.00B₩ 457.59B₩ 548.39B
Stockholders' Equity₩ 246.42B₩ 160.76B₩ 169.54B₩ 191.24B₩ 152.91B
Cash Flow
Free Cash Flow₩ 5.30B₩ 14.24B₩ -54.80B₩ -73.15B₩ -31.16B
Operating Cash Flow₩ 18.95B₩ 28.29B₩ -36.62B₩ -53.54B₩ -11.37B
Investing Cash Flow₩ -2.28B₩ 18.46B₩ -20.36B₩ -26.44B₩ -43.37B
Financing Cash Flow₩ -24.09B₩ -27.85B₩ 58.15B₩ -3.29B₩ 104.32B
Currency in KRW

Ildong Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Ildong Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Ildong Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Ildong Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >